Personnel Information

写真a

MIKI Yoshio


Job title

Professor

Laboratory Address

1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, JAPAN

Mail Address

The inquiry by e-mail is 《here

Homepage URL

http://www.tmd.ac.jp/mri/mgen/index_j.html

Research Areas, Keywords

Carcinogenesis, Breast Cancer, Genome Medicine, Hereditary Cancer, Genome Stability Research

Graduating School 【 display / non-display

  • Wakayama Medical University, Faculty of Medicine, 1981.03, Graduated

Graduate School 【 display / non-display

  • Hyogo College of Medicine, Graduate School, Division of Medicine, Doctor's Course, Completed

Campus Career 【 display / non-display

  • 2002.04
    -
    Now
    Tokyo Medical and Dental University, Medical Research Institute, Medical Genomics, Molecular Genetics, Professor
  • 2002.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Applied Gene Medicine, Professor

External Career 【 display / non-display

  • , Trainee Resident

Research Areas 【 display / non-display

  • Tumor biology

  • Pathological medical chemistry

  • Human genetics

  • Medical genome science

Qualification Acquired 【 display / non-display

  • Doctor

 

Research Theme 【 display / non-display

  • Molecular Mechanisms of Breast Cancer Progression

  • Cancer Genome Research

  • Cell Death Signaling in Cancer

  • DNA Damage Repair and Genome Instability in Cancer

  • Hormone-Dependent Breast Cancer Cell Growth

display all >>

Published Papers & Misc 【 display / non-display

  • Osumi H, Shinozaki E, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Takahari D, Ooki A, Suzuki T, Ota Y, Nakayama I, Chin K, Miki Y, Yamaguchi K. Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer. International journal of cancer. 2019.04; ( PubMed, DOI )

  • Sunada Shigeaki, Miki Yoshio. DNA-PK inhibition releases PARP inhibitor-induced DNA replication stress CANCER SCIENCE. 2018.12; 109 833.

  • Tojo Yo, Sato Ami, Saito Hiroko, Nakanishi Akira, Miki Yoshio. Analysis of the function of estrogen-mediated BRCA2 CANCER SCIENCE. 2018.12; 109 1136.

  • Deng Yu, Nakanishi Akira, Miki Yoshio. Analysis of disruption mechanism of the breast duct and basement membrane by estradiol CANCER SCIENCE. 2018.12; 109 1161.

  • Miki Yoshio, Tomita Naohiro. An update on hereditary tumors CANCER SCIENCE. 2018.12; 109 777.

display all >>

Conference Activities & Talks 【 display / non-display

  • 三木 義男. HBOC(遺伝性乳癌卵巣癌症候群) 遺伝子パネルによる乳がん発症危険度の遺伝学的検査 有効性・課題・展望. 日本癌治療学会学術集会抄録集 2018.10.01

  • 砂田 成章, 三木 義男. DNA-PK阻害はPARP阻害剤誘発のDNA複製ストレスを回避させる(DNA-PK inhibition releases PARP inhibitor-induced DNA replication stress). 日本癌学会総会記事 2018.09.01

  • 東條 陽, 佐藤 亜美, 斉藤 広子, 中西 啓, 三木 義男. エストロゲン誘導性BRCA2の機能解析(Analysis of the function of estrogen-mediated BRCA2). 日本癌学会総会記事 2018.09.01

  • Deng Yu, 中西 啓, 三木 義男. エストロゲンによる乳管及び基底膜崩壊機構の解析(Analysis of disruption mechanism of the breast duct and basement membrane by estradiol). 日本癌学会総会記事 2018.09.01

  • Osumi Hiroki, Shinozaki Eiji, Mashima Tetsuo, Wakatsuki Takeru, Suenaga Mitsukuni, Ichimura Takashi, Ogura Mariko, Ota Yumiko, Nakayama Izuma, Takahari Daisuke, Chin Keisho, Miki Yoshio, Yamaguchi Kensei. Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer(和訳中). Cancer Science 2018.08.01

display all >>